1Schlumberger MJ. Papillary and follicular thyroid carcinoma [J]. N Engl J Med, 1998, 338(5): 297-306.
2Siegel R, Ward E, Brawley O. et al. Cancer statistics, 2011 : the impact of eliminating socioeconomic and racial disparities on premature cancer deaths [J]. CA Cancer J Clin, 2011, 61(4):212-236.
3Wang Y, Wang W. Increasing incidence of thyroid cancer in Shanghai, China, 1983-2007 [J]. Asia Pac J Public Health, 2012, Mar 16. [Epub ahead of print].
5Beeker DV, Clark TS. Radioiodine and thyroid disease: the beginning [J]. Semin Nucl Med, 1996, 26(3): 155-164.
6Cooper DS, Doherty GM, Haugen BR, et al. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2009, 19(11): 1167-1214.
7Taylor T, Specker B, Robbins J, et al. Outcome after treatment of high-risk papillary and non-Hiirthle-cell follicular thyroid carcinoma [J]. Ann intern Med, 1998, 129(8): 62-627.
8Tsang RW, Brierley JD, Simpson WJ, et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma [J]. Cancer, 1998, 82(2): 375-388.
9Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer [J]. J Clin Endocrinol Metab, 2001, 86(4): 1447-1463.
10Wartofsky L, Sherman Si, Gopal J, et al. The use of radioactive iodine in patients with papillary and follicular thyroid cancer [J]. J Clin Endocrinol Metab, 1998, 83(12): 4195-4203.
二级参考文献8
1Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002 [J]. JAMA, 2006, 295(18): 2164-2167.
2Albores-Saavedra J, Henson DE, Glazer E,et al. Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study[J]. Endocr Pathol,2007, 18(1): 1-7.
3Kilfoy BA, Devesa SS, Ward MH, etal. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland [J]. Cancer Epidemiol Biomarkers Prey,2009, 18(4):1092-1100.
4ZhuC, Zheng T, Kitfoy BA,et al. A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004[J]. Thyroid,2009, 19(10):1061-1066.
5Yu GP, Li JC, Branovan D,et al. Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups [J]. Thyroid,2010, 20 (5):465-473.
6Enewold L, Zhu K, Ron E,et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005 [J ]. Cancer Epidemiol Biomarkers Prey,2009, 18(3): 784-791.
7Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005 [J]. Cancer, 2009, 115(16):3801-3807.
8Anna Christina Pfannenberg,Susanne Martina Eschmann,Marius Horger,Regina Lamberts,Reinhard Vonthein,Claus D. Claussen,Roland Bares. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms[J] 2003,European Journal of Nuclear Medicine and Molecular Imaging(6):835～843
